Want to join the conversation?
$JNJ said about 25% of its US orthopedic and surgery business is in multi-product line agreements. These agreements perform almost two times better than single-product contract agreements. The company stated that it sees this percentage growing to 40% in the near future, which it believes will help it accelerate its business going forward.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.